1S1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Viridian Therapeutics Inc

Watchlist Manager

Watchlist

Price: 15.7 EUR 31.93%

Market Cap: €1B

V	Viridian Therapeutics Inc F:1S1	US
	Nextera Energy Inc NYSE:NEE	US
V	Vistra Corp F:0V6	US
S	Sarepta Therapeutics Inc SWB:AB3A	US
A	Akamai Technologies Inc SWB:AK3	US
W	W R Berkley Corp F:WR1	US
L	Lithium Americas Corp F:WUC1	CA
W	Wesfarmers Ltd SWB:WF3	AU
D	Digital Realty Trust Inc SWB:FQI	US
O	Orion Oyj F:OFK	FI
	Saipem SpA F:SPE1	IT
S	Sun Communities Inc F:SCZ	US
	Asahi Kasei Corp F:ASA	JP
	Compagnie Immobiliere de Belgique LSE:0NC0	BE

Profitability Summary

Viridian Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Negative Operating Margin

-459%

Negative 3Y Average Operating Margin

-64.244%

Operating Margin is Increasing

-10.832% > -459%

Negative Net Margin

-484%

Negative 3Y Average Net Margin

-59.014%

Net Margin is Increasing

-10.320% > -484%

Negative Free Cash Flow Margin

-391%

Negative 3Y Average Free Cash Flow Margin

-48.813%

Free Cash Flow Margin is Increasing

-8.114% > -391%

Negative ROE

-49%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-2.882%

ROIC is Increasing

-3.582% > -1.677%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.